Parathyroid Diseases: Clinical Trials

76 trials for Parathyroid Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed, 7 terminated, 6 unknown, 5 recruiting. 76 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 476Completed 55, Terminated 7, Unknown 6, Recruiting 5, Withdrawn 2, Active not recruiting 1

Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases

Trials (filtered) newest first · largest first

All 76 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism
Indapamide 1.5 MG SR, Placebo - Hypoparathyroidism Post-surgical
Phase 4RecruitingLars Rejnmark242025-08-012025-08-11
Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism
Zoledronic acid 4 mg, Natriumklorid 9 mg/ml, Fresenius Kabi - Primary Hyperparathyroidism
Phase 4RecruitingUniversity of Aarhus1402025-03-012026-10-01
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
Indocyanine green, SPY Portable Handheld Imaging - Parathyroid Dysfunction, Adenoma
Phase 4TerminatedUniversity of Alabama at Birmingham4172024-04-112026-05-06
Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
palicalcitol - Chronic Kidney Disease-Mineral and Bone Disorder
Phase 4UnknownXiaoyan Jia802023-04-012024-03-08
PRevEnting FracturEs in REnal Disease - 1
Denosumab 60 mg/ml, Calcium and vitamin D prophylaxis, Monitoring of post-injection calcium and phosphate - Kidney Diseases, Dialysis; Complications
Phase 4Active not recruitingWestern University, Canada602022-06-112025-05-31
Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
Vitamin D, Placebo Oral Tablet - Restless Leg Disorder, Renal Disease Bone
Phase 4WithdrawnUniversity of Sao Paulo General Hospital2022-03-312021-09-30
Ropivacaine Plus Magnesium Sulphate Infiltration
Placebo Comparator: N/S 0.9%, Ropivacaine 10%, Ropivacaine 10% plus magnesium sulphate 10mg/kg - Thyroid Diseases, Parathyroid Diseases
Phase 4CompletedAristotle University Of Thessaloniki682022-01-192024-07-17
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Teriparatide, DXA,VFA, X-ray, HR-pQCT, 18-F NAF PET/CT, Bone biopsy - Adynamic Bone Disease, Chronic Kidney Diseases
Phase 4RecruitingDitte Hansen482021-12-152024-04-23
Lidocaine And Neuromonitoring in Thyroid Surgery
Intravenous lidocaine, Intravenous placebo, Intra-cuff lidocaine - Thyroid Neoplasm, Parathyroid Neoplasms
Phase 4CompletedSaint Petersburg State University, Russia1102021-01-252024-03-21
The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients.
Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland)., Placebo oral sweetener (Clio tablets, sweetener with a dispenser, Instantina GES, Vienna, Austria)., Preoparative blood laboratory tests - Hypocalcemia, Vitamin D Deficiency
Phase 4UnknownMedical University of Lodz1002020-07-012022-02-08
Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism
Calcium Carbonate, Calcium Citrate - Chronic Hypoparathyroidism
Phase 4CompletedCampus Bio-Medico University262019-10-152020-04-03
Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment
Indocyanine Green - Thyroid Cancer, Thyroid Goiter
Phase 4CompletedUniversity Health Network, Toronto102019-08-062020-03-27
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
Calcitonin - Primary Hyperparathyroidism, Hypercalcemia
Phase 4RecruitingJoseph Sferra372019-05-292024-09-19
Osteoporosis in Primary Hyperparathyroidism
Denosumab 60 MG/ML Prefilled Syringe [Prolia], Zoledronic Acid - Primary Hyperparathyroidism, Osteoporosis
Phase 4UnknownUniversity Medical Centre Ljubljana402019-05-082022-11-04
Burosumab in Children and Adolescents With X-linked Hypophosphatemia
Burosumab Injection - Rare Diseases, X-linked Hypophosphatemia
Phase 4UnknownBicetre Hospital572018-03-182020-06-05
Minimizing Narcotic Analgesics After Endocrine Surgery
Acetaminophen 500Mg Cap, Tylenol #3 Oral Tablet, Tramadol - Thyroid Cancer, Thyroid Nodule
Phase 4CompletedMinerva A Romero Arenas1262018-03-092021-05-11
Different Effects of Non-calcium Phosphate Binders on Serum Calcium
Sevelamer Hydrochloride, Lanthanum Carbonate - Chronic Kidney Disease
Phase 4CompletedMedical University of Lodz342018-03-012021-07-27
A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)
rhPTH (1-84), Placebo - Hypoparathyroidism
Phase 4CompletedShire932018-01-242023-06-09
Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients
cardiac MRI, echocardiography with strain, Laboratory tests - Secondary Hyperparathyroidism, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 4CompletedRainer Oberbauer622017-10-012020-06-09
Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Cinacalcet HCl - Hyperparathyroidism; Secondary, Renal
Phase 4CompletedKyowa Kirin China Pharmaceutical Co., Ltd.7502017-04-192024-04-29

Showing 20 of 76. Sign in to see all of them.

Narrower conditions

Hyperparathyroidism, Secondary (42)  ·  Renal Insufficiency, Chronic (19)  ·  Hyperparathyroidism (12)  ·  Hyperparathyroidism, Primary (10)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (9)  ·  Hypercalcemia (9)  ·  Vitamin D Deficiency (9)  ·  Kidney Failure, Chronic (8)  ·  Hypoparathyroidism (7)  ·  Bone Diseases, Metabolic (5)  ·  Osteoporosis (5)  ·  Renal Insufficiency (4)  ·  Hyperphosphatemia (3)  ·  Hypocalcemia (3)  ·  Kidney Diseases (3)

Broader conditions

Endocrine System Diseases (76)  ·  Hyperparathyroidism (52)  ·  Pathological Conditions, Signs and Symptoms (40)  ·  Pathologic Processes (35)  ·  Female Urogenital Diseases (34)  ·  Female Urogenital Diseases and Pregnancy Complications (34)  ·  Male Urogenital Diseases (34)  ·  Urogenital Diseases (34)  ·  Urologic Diseases (34)  ·  Nutritional and Metabolic Diseases (33)  ·  Disease Attributes (32)  ·  Chronic Disease (31)  ·  Kidney Diseases (31)  ·  Metabolic Diseases (30)

Interventions

paricalcitol (19)  ·  Cinacalcet (18)  ·  1 alpha-hydroxyergocalciferol (10)  ·  Calcitriol (9)  ·  Vitamin D (6)  ·  Ergocalciferols (4)  ·  Cholecalciferol (3)  ·  Denosumab (3)  ·  Zoledronic Acid (3)  ·  Alendronate (2)  ·  Indocyanine Green (2)  ·  Sevelamer (2)  ·  Acetaminophen (1)  ·  Atorvastatin (1)  ·  Blood Specimen Collection (1)

Sponsors

Amgen (8)  ·  Abbott (7)  ·  Genzyme, a Sanofi Company (4)  ·  Columbia University (3)  ·  Medical University of Lodz (2)  ·  Papageorgiou General Hospital (2)  ·  Shire (2)  ·  The University of Hong Kong (2)  ·  University of Sao Paulo General Hospital (2)  ·  AbbVie (prior sponsor, Abbott) (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Bicetre Hospital (1)  ·  Campus Bio-Medico University (1)  ·  Chinese University of Hong Kong (1)  ·  Chulalongkorn University (1)

Countries

United States (26)  ·  Denmark (6)  ·  Italy (5)  ·  Spain (4)  ·  Brazil (3)  ·  Canada (3)  ·  China (3)  ·  France (3)  ·  Greece (3)  ·  Hong Kong (3)  ·  Austria (2)  ·  Germany (2)  ·  Israel (2)  ·  Netherlands (2)  ·  Poland (2)

Top investigators

Efstathios Mitsopoulos, MD (2)  ·  Aihua Zhang (1)  ·  Aili Jiang (1)  ·  Anat Tsur, MD (1)  ·  Angela YM Wang, MD PhD (1)  ·  Angela YM Wang, MD, PhD (1)  ·  Anna Grzegory, MD (1)  ·  Anne F Cailleux, MD (1)  ·  Bruno Niederle, Prof., MD (1)  ·  Chaosheng Chen (1)  ·  Csaba P. Kovesdy, M.D. (1)  ·  Daniel W Coyne, MD (1)

Results publications

PMID 17666472, PMID 18178780, PMID 18423809, PMID 19018785, PMID 19365139, PMID 19470620, PMID 20943783, PMID 22387567, PMID 22863242, PMID 23705925, PMID 24214232, PMID 24500308, PMID 24589316, PMID 24970869, PMID 25645432, PMID 25781618, PMID 25873267, PMID 31014177, PMID 31310310, PMID 31651370, PMID 32738041, PMID 33825489, PMID 34754193, PMID 35559350, PMID 35872799, PMID 35974422, PMID 36018496, PMID 36869794, PMID 37729887, PMID 37932788, PMID 38040277, PMID 40576086, PMID 40711996, PMID 40935429, PMID 41847596

NIH funding

2008 (2), 2009 (1), 2017 (1), 2018 (1), 2023 (1), R01DK032333 (1), R01DK084986 (1)